Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114682) titled 'Efficacy and Safety of Different Doses of Midazolam for 24-Hour Continuous Sedation in Pre-Eclamptic Women Undergoing Cesarean Section' on Dec. 16, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Zhuji People's Hospital
Condition:
Preeclampsia
Intervention:
Group D:Intravenous midazolam 0.03 mg/kg
Group B:Intravenous midazolam 0.01mg/kg
Group A:Intravenous midazolam 0 mg/kg
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-01-01
Target Sample Size: Group D:31;Group B:31;Group A:31;Group C:31;
Countries of Recruitment:
China
To know more, vis...